Of course, our current findings are also indicative for the clinical management of LIHC and UCEC, such as the design of kits for the diagnosis of early-stage endometrial and hepatocellular carcinomas (containing primers, probes, or antibodies targeting the WDHD1 gene), which will lead to a more accurate and rapid diagnosis of the two tumors. This evidence concerns the gene WDHD1 and hepatocellular carcinoma.